# Federal Register #2026-22507

FMCSA grants seizure-related driving exemptions to 12 commercial drivers

**Buyer:** Federal Motor Carrier Safety Administration (FMCSA), U.S. Department of Transportation
**Posted:** November 04, 2026
**Identifier:** 2026-22507

This is a Federal Motor Carrier Safety Administration (FMCSA) regulatory notice granting exemptions to 12 drivers with seizure histories, not a procurement opportunity.
- Government buyer: U.S. Department of Transportation, Federal Motor Carrier Safety Administration (FMCSA); no procurement office or buying activity is identified.
- Exemptions allow the 12 drivers to operate commercial motor vehicles in interstate commerce despite the medical qualification restriction covering epilepsy and similar conditions that may cause loss of consciousness or vehicle control.
- Drivers take anti-seizure medication and must remain seizure-free, keep treatment stable, and report seizures or treatment changes.
- Ongoing requirements include annual physician reports, certified driving records, annual medical examinations, reporting specified crashes and citations, and carrying a copy of the exemption while driving.
- No OEMs, vendors, products, quantities, or services are requested.

### Description

The Federal Motor Carrier Safety Administration (FMCSA) announces its decision to exempt 12 individuals from the federal medical qualification requirement concerning epilepsy and other conditions that may cause loss of consciousness or loss of vehicle control. The exemptions allow the individuals, who have seizure histories and take anti-seizure medication, to operate commercial motor vehicles in interstate commerce. The exemptions took effect July 4, 2026, and expire July 4, 2028, subject to specified medical reporting, examination, and driving-record requirements.

[View original listing](https://www.federalregister.gov/documents/2026/11/04/2026-22507/qualification-of-drivers-exemption-applications-epilepsy-and-seizure-disorders)